Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bright Minds Biosciences Inc (DRUG)

Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,637
  • Shares Outstanding, K 4,434
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,470 K
  • 60-Month Beta 1.45
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.97
Trade DRUG with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.31
  • Most Recent Earnings $-0.32 on 02/12/24
  • Latest Earnings Date 05/20/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9300 +6.45%
on 04/30/24
1.3792 -28.22%
on 04/04/24
-0.2900 (-22.66%)
since 04/03/24
3-Month
0.9300 +6.45%
on 04/30/24
2.3900 -58.58%
on 02/05/24
-1.1700 (-54.17%)
since 02/02/24
52-Week
0.9300 +6.45%
on 04/30/24
6.4400 -84.63%
on 08/08/23
-2.0720 (-67.67%)
since 05/03/23

Most Recent Stories

More News
Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by Management

/CNW/ - Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) ("Bright Minds" or the "Company"), a leading biotechnology company specializing in the...

DRUG.CN : 1.3700 (+5.38%)
DRUG : 0.9900 (-5.34%)
Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year’s End

EQNX::TICKER_START (NYSE:PTN),(NASDAQ:CRDF),(NASDAQ:BDRX),(NASDAQ:DRUG),(NYSE:LLY) EQNX::TICKER_END

CRDF : 3.52 (-21.43%)
BDRX : 1.1800 (-4.84%)
DRUG : 0.9900 (-5.34%)
LLY : 734.97 (-2.77%)
PTN : 2.11 (+2.93%)
Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year's End

/PRNewswire/ -- About 9.4% of the world population is aged 65 or above. Older people typically consume more medicines than the people in other age group...

PTN : 2.11 (+2.93%)
CRDF : 3.52 (-21.43%)
BDRX : 1.1800 (-4.84%)
DRUG : 0.9900 (-5.34%)
LLY : 734.97 (-2.77%)
New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences

A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking psychedelics can have the same transformational effects as a near-death experience (NDE). The study...

HCA : 307.76 (-0.35%)
DRUG : 0.9900 (-5.34%)
DRUG.CN : 1.3700 (+5.38%)
LFST : 6.66 (+1.99%)
NUMIF : 0.0518 (-0.77%)
NUMI.TO : 0.0700 (unch)
ACHC : 66.12 (-0.91%)
New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences

/PRNewswire/ -- A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking psychedelics can have the same...

NUMI.TO : 0.0700 (unch)
DRUG.CN : 1.3700 (+5.38%)
NUMIF : 0.0518 (-0.77%)
HCA : 307.76 (-0.35%)
DRUG : 0.9900 (-5.34%)
LFST : 6.66 (+1.99%)
ACHC : 66.12 (-0.91%)
New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – October 5, 2022 –  A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking...

HCA : 307.76 (-0.35%)
DRUG : 0.9900 (-5.34%)
DRUG.CN : 1.3700 (+5.38%)
LFST : 6.66 (+1.99%)
ACHC : 66.12 (-0.91%)
NUMI.TO : 0.0700 (unch)
NUMIF : 0.0518 (-0.77%)
Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

VANCOUVER, British Columbia, June 27, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE:...

OTC.VN : 0.325 (+3.17%)
DRUG : 0.9900 (-5.34%)
DRUG.CN : 1.3700 (+5.38%)
Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

VANCOUVER, British Columbia, June 27, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE:...

OTC.VN : 0.325 (+3.17%)
DRUG : 0.9900 (-5.34%)
DRUG.CN : 1.3700 (+5.38%)
Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet Syndrome

-- Review of Phase I ready BMB-101 and upcoming milestones -- -- Webcast to be held on May 19, 2022, 4:00pm ET -- VANCOUVER, British Columbia, May ...

OTC.VN : 0.325 (+3.17%)
DRUG : 0.9900 (-5.34%)
DRUG.CN : 1.3700 (+5.38%)
Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health Specialties

-- Herbert Y. Meltzer, MD; Karl Deisseroth, MD, PhD; Robert C. Malenka, MD, PhD; Michael P. Bogenschutz, MD; and Peter Hendricks, PhD, bring decades of...

DRUG.CN : 1.3700 (+5.38%)
DRUG : 0.9900 (-5.34%)
OTC.VN : 0.325 (+3.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bright Minds Biosciences is a biotechnology company. It focused on developing novel drugs for targeted treatment of neuropsychiatric disorders, epilepsy and pain. Bright Minds Biosciences is based in VANCOUVER, British Columbia.

See More

Key Turning Points

3rd Resistance Point 1.1200
2nd Resistance Point 1.0900
1st Resistance Point 1.0400
Last Price 0.9900
1st Support Level 0.9600
2nd Support Level 0.9300
3rd Support Level 0.8800

See More

52-Week High 6.4400
Fibonacci 61.8% 4.3352
Fibonacci 50% 3.6850
Fibonacci 38.2% 3.0348
Last Price 0.9900
52-Week Low 0.9300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar